PAVmed Inc. (NASDAQ:PAVM – Get Free Report) was the target of a significant growth in short interest in December. As of December 15th, there was short interest totalling 271,700 shares, a growth of 27.2% from the November 30th total of 213,600 shares. Approximately 3.7% of the company’s stock are short sold. Based on an average […]
PAVmed (NASDAQ:PAVM – Get Free Report) and Sigyn Therapeutics (OTCMKTS:SIGY – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations and valuation. Analyst Ratings This is a summary of current […]
Cantor Fitzgerald reissued their neutral rating on shares of PAVmed (NASDAQ:PAVM – Free Report) in a report issued on Friday, Benzinga reports. The brokerage currently has a $1.40 price objective on the stock. PAVmed Stock Down 5.6 % Shares of PAVM opened at $0.23 on Friday. PAVmed has a twelve month low of $0.21 and […]
Levin Capital Strategies L.P. boosted its position in shares of PAVmed Inc. (NASDAQ:PAVM – Get Rating) by 86.8% during the 4th quarter, HoldingsChannel.com reports. The firm owned 279,750 shares of the company’s stock after purchasing an additional 130,000 shares during the period. Levin Capital Strategies L.P.’s holdings in PAVmed were worth $134,000 as of its […]
PAVmed (NASDAQ:PAVM – Get Rating) and Artivion (NYSE:AORT – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, dividends, analyst recommendations and valuation. Valuation and Earnings This table compares PAVmed and Artivion’s revenue, earnings […]